MyLungCancerTeam

Imdelltra, also known as tarlatamab-dlle, is a biologic drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with extensive stage small cell lung cancer (SCLC) whose disease has progressed after undergoing platinum-based chemotherapy. It works by binding to the DLL3 protein on Show Full Answer

Imdelltra, also known as tarlatamab-dlle, is a biologic drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with extensive stage small cell lung cancer (SCLC) whose disease has progressed after undergoing platinum-based chemotherapy. It works by binding to the DLL3 protein on cancer cells and activating T-cells to attack these cells. It is administered as an intravenous (IV) infusion.

For more detailed information, you can visit the source: [Imdelltra (Tarlatamab-Dlle) for Lung Cancer | MyLungCancerTeam](https://www.mylungcancerteam.com/treatments/imd...).

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Imdelltra (Tarlatamab-Dlle) for Lung Cancer | MyLungCancerTeam

Does Immunotherapy for Lung Cancer Work? | MyLungCancerTeam